Jubilant Life Sciences Limited announced that Mr. Sankaraiah Rajagopal, Executive Director-Finance and Key Managerial Personnel will be superannuating from the services of the Company on March 31, 2020 and shall continue to be an advisor to the Group. The Board has, at its meeting held on October 25, 2019, approved the appointment of Mr. Alok Vaish as Chief Financial Officer and Key Management Personnel of the Company effective from April 1, 2020. Mr. Vaish has joined the Company effective immediately, as Chief Financial Officer Designate.

Prior to joining the Company, Mr. Vaish was working with Yatra Online Private Limited for more than 11 years as Group Chief Financial Officer and also worked with HSIL Limited, Ambit Corporate Finance Pte, Deutsche Bank, New York and Bajaj Auto Limited in various leadership roles.